Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

653 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Malignant mesothelioma: new insights into a rare disease.
Remon J, Lianes P, Martínez S, Velasco M, Querol R, Zanui M. Remon J, et al. Cancer Treat Rev. 2013 Oct;39(6):584-91. doi: 10.1016/j.ctrv.2012.12.005. Epub 2012 Dec 28. Cancer Treat Rev. 2013. PMID: 23276688 Review.
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients.
Remon J, Girard N, Novello S, de Castro J, Bigay-Game L, Bernabé R, Greillier L, Mosquera J, Cousin S, Juan O, Sampayo M, Besse B. Remon J, et al. Clin Lung Cancer. 2022 May;23(3):e243-e246. doi: 10.1016/j.cllc.2021.07.008. Epub 2021 Jul 20. Clin Lung Cancer. 2022. PMID: 34393061 Clinical Trial.
Dynamics of eligibility criteria for central nervous system metastases in non-small cell lung cancer randomized clinical trials over time: A systematic review.
Schoenmaekers JJAO, Dursun S, Biesmans C, De Ruysscher DKM, Broen MPG, Remon J, Dingemans AC, Hendriks LEL. Schoenmaekers JJAO, et al. Among authors: remon j. Crit Rev Oncol Hematol. 2021 Oct;166:103460. doi: 10.1016/j.critrevonc.2021.103460. Epub 2021 Aug 26. Crit Rev Oncol Hematol. 2021. PMID: 34454057 Free article. Review.
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA.
Remon J, Lacas B, Herbst R, Reck M, Garon EB, Scagliotti GV, Ramlau R, Hanna N, Vansteenkiste J, Yoh K, Groen HJM, Heymach JV, Mandrekar SJ, Okamoto I, Neal JW, Heist RS, Planchard D, Pignon JP, Besse B; ANSELMA collaborative group. Remon J, et al. Eur J Cancer. 2022 May;166:112-125. doi: 10.1016/j.ejca.2022.02.002. Epub 2022 Mar 11. Eur J Cancer. 2022. PMID: 35286903 Review.
653 results